Mirvaso 5 mg/g
brimonidine tartrate · GEL · Galderma Laboratories, L.P.
No Recall History
Plain English
Mirvaso is a gel containing brimonidine tartrate at 5 mg/g, taken topical. Manufactured by Galderma Laboratories, L.P..
Key Facts
- Brand Name
- Mirvaso
- Generic Name
- brimonidine tartrate
- NDC Code (Product)
0299-5980- Manufacturer
- Galderma Laboratories, L.P.
- Strength
- 5 mg/g
- Dosage Form
- GEL
- Route
- TOPICAL
- Marketing Status
- Application #
- NDA204708
- Marketing Start
- 08/23/2013
Recall History
No Recall HistoryFrequently Asked Questions
What is Mirvaso used for?
Mirvaso contains brimonidine tartrate. It is a gel taken topical. Consult your doctor for specific uses.
Is Mirvaso a controlled substance?
Mirvaso is not classified as a controlled substance by the DEA.
What is the generic name for Mirvaso?
The generic name for Mirvaso is brimonidine tartrate. There are 11 other brand versions of brimonidine tartrate.
What is the NDC code for Mirvaso 5 mg/g?
The NDC (National Drug Code) for Mirvaso 5 mg/g is 0299-5980, listed by Galderma Laboratories, L.P..
Other Brimonidine Brands
See all →- Brimonidine Tartrate2 mg/mg14445-400
- LUMIFY PRESERVATIVE FREE EYE DROPS.25 mg/mL24208-538
- Brimonidine Tartrate1 mg/mL46708-749
- Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution2 mg/mL65145-162
- Brimonidine tartrate1 mg/mL82182-321
- Brimonidine1 mg/mL0781-7177
- ALPHAGAN P1.5 mg/mL0023-9177
- ALPHAGAN P1 mg/mL0023-9321
- Brimonidine Tartrate1 mg/mL62332-749
- Brimonidine Tartrate1.5 mg/mL60505-0564
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)